CHEK2*1100delC is a moderate-risk breast cancer susceptibility allele with a relatively high prevalence in the Netherlands of 1.1 % in the general population, 2.5 % in unselected breast cancer cases, and 4.9 % in familial breast cancer cases. This evidence concerns the gene CHEK2 and breast carcinoma.